Bone mineral density of Brazilian girls with juvenile dermatomyositis

被引:17
作者
de Castro, TCM
Terreri, MTR
Szejnfeld, VL
Len, C
da Fonseca, ASM
Hilário, MOE
机构
[1] Univ Fed Sao Paulo, Escola Paulista Med, Div Alergia Immunol & Reumatol, Dept Pediat, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Dept Med Interna, Sao Paulo, Brazil
[3] Univ Fed Rio Grande Norte, Dept Pediat, BR-59072970 Natal, RN, Brazil
关键词
dermatomyositis; adolescent girls; bone mineral density; osteoporosis; corticosteroids;
D O I
10.1590/S0100-879X2005000200020
中图分类号
Q [生物科学];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
We measured bone mineral density (BMD) in girls with juvenile dennatomyositis (JDM) considering multiple factors in order to determine if it could be used as a predictor of reduction in bone mass. A cross-sectional study of lumbar spine BMD (L2-L4) was conducted on 10 girls aged 7-16 years with JDM. A group of 20 age-matched healthy girls was used as control. Lumbar spine BMD was measured by dual-energy X-ray absorptiometry. Weight, height and pubertal Tanner stage were determined in all patients and controls. Duration of disease and mean daily and cumulative steroid doses were calculated for all patients on the basis of their medical charts. JDM activity was determined on the basis of the presence of muscle weakness, cutaneous vasculitis and/or elevation of serum concentration of one or more skeletal muscle enzymes. Seven patients demonstrated osteopenia or osteoporosis. Lumbar BMD was significantly lower in the JDM patients than the age-matched healthy control girls (0.712 vs 0.878, respectively; Student t-test, P = 0.041). No significant correlation between BMD and age, height, Tanner stage, disease duration, corticosteroid use, or disease activity was observed in JDM girls, but a correlation was observed between BMD and weight (Pearson's correlation coefficient, r = 0.802). Patients with JDM may be at risk for a significant reduction in BNM that might contribute to further skeletal fragility. Our results suggest that reduced bone mass in JDM may be related to other intrinsic mechanisms in addition to steroid treatment and some aspects of the disease itself may contribute to this condition.
引用
收藏
页码:309 / 313
页数:5
相关论文
共 30 条
[1]
BABINI SM, 1988, J RHEUMATOL, V15, P1162
[2]
POLYMYOSITIS AND DERMATOMYOSITIS .1. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) :344-347
[3]
CRITICAL YEARS AND STAGES OF PUBERTY FOR SPINAL AND FEMORAL BONE MASS ACCUMULATION DURING ADOLESCENCE [J].
BONJOUR, JP ;
THEINTZ, G ;
BUCHS, B ;
SLOSMAN, D ;
RIZZOLI, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (03) :555-563
[4]
Brik R, 1998, J RHEUMATOL, V25, P990
[5]
Cassidy JT, 1999, CLIN EXP RHEUMATOL, V17, P245
[6]
DESCHEPPER J, 1991, J NUCL MED, V32, P216
[7]
ASSESSMENT OF THE EFFECT OF ORAL CORTICOSTEROIDS ON BONE-MINERAL DENSITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PRELIMINARY-STUDY WITH DUAL ENERGY X-RAY ABSORPTIOMETRY [J].
DHILLON, VB ;
DAVIES, MC ;
HALL, ML ;
ROUND, JM ;
ELL, PJ ;
JACOBS, HS ;
SNAITH, ML ;
ISENBERG, DA .
ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (08) :624-626
[8]
EFFECT OF ORAL 1,25-DIHYDROXYVITAMIN-D AND CALCIUM ON GLUCOCORTICOID-INDUCED OSTEOPENIA IN PATIENTS WITH RHEUMATIC DISEASES [J].
DYKMAN, TR ;
HARALSON, KM ;
GLUCK, OS ;
MURPHY, WA ;
TEITELBAUM, SL ;
HAHN, TJ ;
HAHN, BH .
ARTHRITIS AND RHEUMATISM, 1984, 27 (12) :1336-1343
[9]
EVALUATION OF FACTORS ASSOCIATED WITH GLUCOCORTICOID-INDUCED OSTEOPENIA IN PATIENTS WITH RHEUMATIC DISEASES [J].
DYKMAN, TR ;
GLUCK, OS ;
MURPHY, WA ;
HAHN, TJ ;
HAHN, BH .
ARTHRITIS AND RHEUMATISM, 1985, 28 (04) :361-368
[10]
Comparison of quantitative calcaneal ultrasound and dual energy x-ray absorptiometry in the evaluation of osteoporotic risk in children with chronic rheumatic diseases [J].
Falcini, F ;
Bindi, G ;
Ermini, M ;
Galluzzi, F ;
Poggi, G ;
Rossi, S ;
Masi, L ;
Cimaz, R ;
Brandi, ML .
CALCIFIED TISSUE INTERNATIONAL, 2000, 67 (01) :19-23